TriSalus Life Sciences (TLSI) EPS (Basic) (2021 - 2026)
TriSalus Life Sciences (TLSI) reported EPS (Basic) of $0.03 for Q1 2026, up 107.69% on a YoY basis from $0.01 in Q1 2025, and up 125.0% quarter-over-quarter from -$0.12 in Q4 2025.
TriSalus Life Sciences (TLSI) EPS (Basic) (2021 - 2026) Analysis & Trends
TriSalus Life Sciences has reported EPS (Basic) for 6 years, with the latest figure at $0.03 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 107.69% year-over-year to $0.03; the trailing twelve-month figure through Mar 2026 stood at -$1.32 (down 17.86% YoY), and the FY2025 full-year result was -$1.84, down 40.46% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.03, up from -$0.12 in the prior quarter.
- The five-year high for EPS (Basic) was $0.09 in Q1 2022, with the low at -$79.38 in Q4 2022.
- Historically, EPS (Basic) has averaged -$8.58 across 5 years, with a median of -$0.39 in 2025.
- The largest YoY upside for EPS (Basic) was 1000.0% in 2022 against a maximum downside of 88300.0% in 2022.
- TriSalus Life Sciences' EPS (Basic) stood at -$79.38 in 2022, then soared by 98.68% to -$1.05 in 2023, then surged by 61.9% to -$0.4 in 2024, then soared by 70.0% to -$0.12 in 2025, then surged by 125.0% to $0.03 in 2026.
- The last three EPS (Basic) figures came in at $0.03 (Q1 2026), -$0.12 (Q4 2025), and -$0.96 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.52 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.25 |
| 10 | TriSalus Life Sciences | 209.25 Mn | 152.70 Mn | 7.67 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -0.96 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.39 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.21 |
| Mar 31, 2024 | -0.60 |
| Dec 31, 2023 | -1.05 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -35.84 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -79.38 |
| Sep 30, 2022 | -25.95 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.01 |